APA

Jagadeesh D., Majhail N. S., He Y., Ahn K. W., Litovich C., Ahmed S., Aljurf M., Bacher U., Badawy S. M., Bejanyan N., Cairo M., Cerny J., Epperla N., Farhadfar N., Freytes C. O., Gale R. P., Haverkos B., Hossain N., Inwards D., Kamble R. T., Kenkre V. P., Lazarus H. M., Lazaryan A., Lekakis L., Mei M., Murthy H. S., Mussetti A., Nathan S., Nishihori T., Olsson R. F., Ramakrishnan Geethakumari P., Savani B. N., Yared J. A., Fenske T. S., Kharfan-Dabaja M. A., Sureda A. & Hamadani M. (20210114). Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. : Cancer.

Chicago

Jagadeesh Deepa, Majhail Navneet S, He Yizeng, Ahn Kwang W, Litovich Carlos, Ahmed Sairah, Aljurf Mahmoud, Bacher Ulrike, Badawy Sherif M, Bejanyan Nelli, Cairo Mitchell, Cerny Jan, Epperla Narendranath, Farhadfar Nosha, Freytes César O, Gale Robert Peter, Haverkos Bradley, Hossain Nasheed, Inwards David, Kamble Rammurti T, Kenkre Vaishalee P, Lazarus Hillard M, Lazaryan Aleksandr, Lekakis Lazaros, Mei Matthew, Murthy Hemant S, Mussetti Alberto, Nathan Sunita, Nishihori Taiga, Olsson Richard F, Ramakrishnan Geethakumari Praveen, Savani Bipin N, Yared Jean A, Fenske Timothy S, Kharfan-Dabaja Mohamed A, Sureda Anna and Hamadani Mehdi. 20210114. Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. : Cancer.

Harvard

Jagadeesh D., Majhail N. S., He Y., Ahn K. W., Litovich C., Ahmed S., Aljurf M., Bacher U., Badawy S. M., Bejanyan N., Cairo M., Cerny J., Epperla N., Farhadfar N., Freytes C. O., Gale R. P., Haverkos B., Hossain N., Inwards D., Kamble R. T., Kenkre V. P., Lazarus H. M., Lazaryan A., Lekakis L., Mei M., Murthy H. S., Mussetti A., Nathan S., Nishihori T., Olsson R. F., Ramakrishnan Geethakumari P., Savani B. N., Yared J. A., Fenske T. S., Kharfan-Dabaja M. A., Sureda A. and Hamadani M. (20210114). Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. : Cancer.

MLA

Jagadeesh Deepa, Majhail Navneet S, He Yizeng, Ahn Kwang W, Litovich Carlos, Ahmed Sairah, Aljurf Mahmoud, Bacher Ulrike, Badawy Sherif M, Bejanyan Nelli, Cairo Mitchell, Cerny Jan, Epperla Narendranath, Farhadfar Nosha, Freytes César O, Gale Robert Peter, Haverkos Bradley, Hossain Nasheed, Inwards David, Kamble Rammurti T, Kenkre Vaishalee P, Lazarus Hillard M, Lazaryan Aleksandr, Lekakis Lazaros, Mei Matthew, Murthy Hemant S, Mussetti Alberto, Nathan Sunita, Nishihori Taiga, Olsson Richard F, Ramakrishnan Geethakumari Praveen, Savani Bipin N, Yared Jean A, Fenske Timothy S, Kharfan-Dabaja Mohamed A, Sureda Anna and Hamadani Mehdi. Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. : Cancer. 20210114.